Two Sigma Advisers’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,256,500
Closed -$127M 445
2025
Q4
$127M Sell
1,256,500
-778,100
-38% -$84.5M 0.25% 93
2025
Q3
$251M Buy
2,034,600
+1,310,100
+181% +$163M 0.5% 46
2025
Q2
$87M Buy
724,500
+686,700
+1,817% +$91.6M 0.18% 123
2025
Q1
$5.57M Sell
37,800
-26,600
-41% -$4.06M 0.01% 743
2024
Q4
$10.5M Buy
+64,400
New +$10.5M 0.02% 474
2024
Q2
Sell
-7,400
Closed -$1.13M 2478
2024
Q1
$1.13M Sell
7,400
-11,700
-61% -$1.75M ﹤0.01% 1529
2023
Q4
$2.72M Sell
19,100
-573,800
-97% -$76.5M 0.01% 1114
2023
Q3
$77.7M Sell
592,900
-391,800
-40% -$59.5M 0.2% 116
2023
Q2
$157M Buy
984,700
+456,200
+86% +$73.6M 0.4% 67
2023
Q1
$83.6M Sell
528,500
-93,500
-15% -$14M 0.22% 105
2022
Q4
$87.3M Sell
622,000
-20,400
-3% -$2.9M 0.24% 89
2022
Q3
$82.5M Buy
642,400
+115,300
+22% +$16.6M 0.24% 105
2022
Q2
$74.3M Buy
527,100
+79,500
+18% +$11.4M 0.21% 112
2022
Q1
$62.2M Sell
447,600
-69,600
-13% -$10.7M 0.17% 134
2021
Q4
$90.2M Buy
517,200
+14,300
+3% +$2.38M 0.23% 102
2021
Q3
$83.3M Buy
+502,900
New +$86.6M 0.22% 99
2021
Q2
Sell
-136,100
Closed -$26.3M 2478
2021
Q1
$26.3M Sell
136,100
-550,200
-80% -$106M 0.07% 290
2020
Q4
$139M Buy
686,300
+298,100
+77% +$61.7M 0.37% 62
2020
Q3
$81.6M Buy
388,200
+375,000
+2,841% +$83.5M 0.23% 100
2020
Q2
$2.9M Sell
13,200
-62,400
-83% -$12.5M 0.01% 1022
2020
Q1
$13.1M Buy
+75,600
New +$12.5M 0.05% 403
2019
Q4
Sell
-32,400
Closed -$4.92M 2367
2019
Q3
$4.92M Buy
+32,400
New +$5.12M 0.01% 768
2019
Q1
Sell
-2,300
Closed -$355K 2314
2018
Q4
$355K Buy
+2,300
New +$358K ﹤0.01% 1905
2018
Q2
Sell
-207,864
Closed -$27.7M 2380
2018
Q1
$27.7M Sell
207,864
-607,570
-75% -$81.6M 0.08% 324
2017
Q4
$121M Buy
815,434
+626,426
+331% +$85.2M 0.33% 74
2017
Q3
$24.9M Buy
189,008
+121,444
+180% +$16.3M 0.07% 312
2017
Q2
$9M Buy
+67,564
New +$9.12M 0.03% 540
2017
Q1
Sell
-402,626
Closed -$48.3M 2353
2016
Q4
$48.3M Buy
402,626
+338,666
+529% +$39.9M 0.18% 125
2016
Q3
$8.01M Buy
+63,960
New +$8.38M 0.03% 486
2016
Q2
Sell
-2,260
Closed -$285K 2064
2016
Q1
$285K Buy
2,260
+209
+10% +$26.6K ﹤0.01% 1699
2015
Q4
$260K Sell
2,051
-103,500
-98% -$12.8M ﹤0.01% 1570
2015
Q3
$12.2M Sell
105,551
-129,000
-55% -$14.5M 0.08% 296
2015
Q2
$24.4M Sell
234,551
-20,893
-8% -$2.25M 0.18% 149
2015
Q1
$28.2M Sell
255,444
-113,800
-31% -$12.4M 0.21% 130
2014
Q4
$38.5M Buy
369,244
+365,300
+9,262% +$36.5M 0.3% 72
2014
Q3
$379K Sell
3,944
-8,700
-69% -$787K ﹤0.01% 1710
2014
Q2
$1.16M Buy
+12,644
New +$1.13M 0.01% 1098
2014
Q1
Sell
-8,944
Closed -$785K 2295
2013
Q4
$830K Buy
+8,944
New +$806K 0.01% 1254

Other funds holding CLX

Two Sigma Advisers's CLX Position: Q1 2026 in Review

Two Sigma Advisers sold out of Clorox (CLX) in Q1 2026, closing a stake of 1,256,500 shares — an estimated $127M sold.

Two Sigma Advisers first reported a position in CLX in Q4 2013 and held it in 38 quarters. The position peaked at $251M in Q3 2025. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Two Sigma Advisers reported no remaining Clorox position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 1,256,500 Clorox shares in Q1 2026, an estimated $127M.
  • Two Sigma Advisers first reported a position in Clorox in Q4 2013 and held it in 38 quarters.
  • Two Sigma Advisers's Clorox position peaked at $251M in Q3 2025.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.